Catalyst Wire Dossier Catalyst Wire Dossier

GLU-xx formulations

· Afexa Life Sciences Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLU-xx formulations, covering 2012-01-31 to 2012-01-31. Get the full timeline:

Most recent: Clinical Trial Update: GLU-xx Formulations in Individuals With Impaired Glucose Tolerance [Phase 1]

See pricing